inflamed.communityinflamed.community

Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration.

Xin P · 2026 · Frontiers in immunology

Reading the original? How to read a paper.

What this paper found

This review maps every kind of marker used to diagnose axial spondyloarthritis, from HLA-B27 and CRP through genomics and metabolomics to MRI read by deep-learning models, and how combining them is starting to shorten the typical two-to-six-year wait for a diagnosis. For anyone who waited years, it explains why, and what is changing.

Why this is on the map

Useful orientation paper tying together the imaging, genetic and blood-test strands that appear separately across the map.

On the map under these threads

Read the paper at the source →

DOI: 10.3389/fimmu.2026.1929862 · opens in a new tab. The full paper is on the publisher’s site, not here.

Related papers on the board

Papers sharing one or more threads with this one.

Huang · 2026
Study

HLA-B27-associated gut microbiota and amino acid perturbations promote ankylosing spondylitis through M1 macrophage activation

Gut Microbes

Shows that HLA-B27, the gene most strongly linked to AS, reshapes which bacteria live in the gut and how the body handles certain amino acids, which in turn activates the inflammatory immune cells driving the disease. Suggests targeting the gut and these metabolic changes could become a real treatment route.

Gut–Immune AxisMacrophage M1 PolarisationHLA-B27 Genetics
Rydning PNF · 2026
Study

Long-term functional and radiological outcomes among survivors of ankylosing spondylitis-associated cervical spine fractures: a cross-sectional follow-up study.

North American Spine Society journal

Among 97 survivors of neck fractures linked to ankylosing spondylitis, followed for a median of four years, most lived independently with mild neck pain and low disability, 96 percent of fractures had healed solidly, and half of those with spinal cord injury recovered fully. These fractures are dangerous at the time, but for those who come through them the long-term picture is better than most people would expect.

Treatment Response & Outcomes
Sun Tiantian · 2026
Study

Plasma Proteomics Identifies Molecular Signatures and Biomarkers Associated with High Structural Damage in Ankylosing Spondylitis

Arthritis & Rheumatology

Measuring hundreds of blood proteins in people with ankylosing spondylitis, researchers found a five-protein signature, driven by platelet and tissue-remodelling proteins rather than classic inflammation markers, that identified those with heavy structural damage with high accuracy in a separate validation group. Bone damage in AS seems to run partly on a different track from inflammation, and a blood test for it looks feasible.

Treatment Response & Outcomes
Felten Renaud · 2026
Study

Preconception, pregnancy and postpartum periods in spondyloarthritis: Unmet needs and challenges from a patients and rheumatologists surveys

Joint Bone Spine

Surveys of French women with spondyloarthritis and their rheumatologists found that pregnancy is not discouraged and usually goes well, but women rated their worry about flares highly, had gaps in knowledge about biologics in pregnancy and delivery, and only a quarter of rheumatologists knew the pregnancy guidelines. The information gap is on both sides of the consultation.

Treatment Response & Outcomes